Migset 25 mg Tablet

Manufactured byCipla Ltd.
ContainsMiglitol
Description

Migset 25 mg Tablet is an antidiabetic used in the treatment of type 2 diabetes for adults. This medicine is not recommended for use in children. It may be used in combination with other antidiabetic medicines. Patients are advised to follow strict diet and exercise regimens along with this medicine to get the best possible effect.

Side effects

Major & minor side effects for Migset 25 mg Tablet

  • Confusion
  • Dizziness and lightheadedness
  • Weakness
  • Shakiness or unsteady walking
  • Increased bowel movements
  • Stomach and abdominal pain
  • Excessive air or gas in stomach
  • Rash

Uses of Migset 25 mg Tablet

What is it prescribed for?

  • Diabetes Type 2
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is approximately 1 hour.
  • Duration of effect
    The time until which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with Migset 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to miglitol.

Diabetic ketoacidosis

This medicine is not recommended for use in patients with a known history of Diabetic ketoacidosis, a life-threatening complication of diabetes mellitus.

Inflammatory bowel disease

Migset 25 mg Tablet is not recommended for use in patients with a known history of Inflammatory bowel disease.

Intestinal Obstruction

This medicine is not recommended for use in patients with a known history of Intestinal Obstruction.

Chronic intestinal diseases

This medicine is not recommended for use in patients with a known history of Chronic intestinal diseases.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.
General warnings

Low blood glucose levels

This medicine should be used with caution due to an increased risk of low blood glucose levels. This risk is especially higher in patients on other anti-diabetic medicines. Frequent monitoring of blood glucose levels is necessary during treatment with this medicine. Appropriate dose adjustments may be done based on the clinical condition.

Gastrointestinal disease

Migset 25 mg Tablet is not recommended for use in patients with any gastrointestinal diseases like inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or any chronic intestinal disease. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next scheduled dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Migset 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.
Interaction with Medicine

Corticosteroids

Furosemide

Gatifloxacin

Disease interactions

Diabetic Ketoacidosis

Migset 25 mg Tablet is not recommended for use in patients with diabetic ketoacidosis. An alternative treatment option should be considered based on the clinical condition of the patient.

Gastro-intestinal disease

Migset 25 mg Tablet is not recommended for use in patients with inflammatory bowel disease or any chronic intestinal disease. An alternative treatment option should be considered based on the clinical condition. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Migset 25 mg Tablet exactly as prescribed by the doctor. The dose of the medicine is likely to change based on your body's response to therapy. It is advisable to undergo blood sugar tests at regular intervals to safely use this medicine. You should always carry a sugar candy with you to overcome unexpected lowering of blood sugar levels. The schedule and duration of use should not be changed without consulting the doctor. Ensure that the course of treatment is completed. Report any adverse effects to the doctor on priority.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Migset 25 mg Tablet works by lowering the blood sugar levels in diabetic patients.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Alpha-glucosidase inhibitors

Schedule

Schedule H

[Internet]. 2017 [cited 7 August 2017]. Available from:

http://ww.tga.gov.au/prescribing-medicines-pregnancy-database

DailyMed - MIGLITOL- miglitol tablet, coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 7 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=192e6ed7-9e8c-4772-9e3b-5912a1c63a31

Miglitol - DrugBank [Internet]. Drugbank.ca. 2017 [cited 7 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00491

Miglitol: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 7 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601079.html
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error